Rule Caps Medicare’s Drug-Plan Base as Premiums Grow
A Medicare rule caps the base drug-plan premium, yet actual plan prices can rise much more. For retirees, that create...
Which index fund performed best this year? Review top performers, volatility, and potential shifts to inform your next move.
26,831 articlesA Medicare rule caps the base drug-plan premium, yet actual plan prices can rise much more. For retirees, that create...
As market volatility persists in 2026, retirees with a $100K variable annuity inside an IRA confront a key choice: ta...
A hard look at how scammers recruit money mules, the risks for seniors, and concrete steps you can take to shield you...
Explore how Fluent's Q1 2026 earnings could shape its year ahead. This article breaks down revenue trends, margins, a...
A tiny stock has surged 680% in a year, grabbing headlines and investor attention. This guide breaks down what’s driv...
Wolverine Worldwide's Q1 2026 earnings call offers a clear view of the company's momentum, margins, and strategic bet...
High earners are pursuing a legal workaround—backdoor roth 401(K) conversions—to move after-tax 401(K) money into Rot...
A rising tax trap could convert a $260,000 401(k) deferral into a looming $700K RMD burden. The piece explains the ma...
A pension election could dramatically reshape survivor finances. A high-wealth household faces a stark tradeoff betwe...
A seasoned journalist spends a year letting AI handle routine work, finding strong productivity gains but ongoing rel...
A 61-year-old engineer worries that being laid off before the Social Security cutoff could erase years of earnings. T...
Target reports its strongest quarterly gain in comparable sales in four years, signaling progress in a broad turnarou...